BIOMED INVEST
BIOMED INVEST
Status:
Active
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-09-12 | Inotrem | BioMed Invest investment in Series B - Inotrem | 39 M EUR |
More informations about "BioMed Invest"
biomedvc.com | Portfolio
BioMedInvest AG I in liquidation was a healthcare-dedicated investment company, providing private equity financing to early- to mid-stage companies in the biotechnology, emerging โฆSee details»
BioMedPartners closes new venture capital fund
Jun 3, 2018 Main investors in the BioMedInvest III healthcare venture capital fund are the European Investment Fund and the Berner Kantonalbank ().According to Markus Hosang, โฆSee details»
BioMedInvest II: Fund Performance - PitchBook
BioMedInvest II General Information Description. BioMedInvest II is a venture capital fund managed by BioMedPartners. The fund is located in Basel, Switzerland and invested in โฆSee details»
BioMed Ventures - Investments, Portfolio & Company Exits
BioMed Ventures 's most notable exits include Compass Therapeutics, Inc., Sensely, and Syndax Pharmaceuticals. Which industries has this organization had the most exits in? ShowSee details»
BioMedInvest has new CHF 95M investment fund - Science|Business
Jan 21, 2009 With this closing, BioMedPartners, founded in 2003, has raised a total of over CHF 240 million (โฌ169.6 million). The new fund, BioMedInvest II, will be dedicated to investing in โฆSee details»
BioMed Ventures - Golden
Founded in 2010, BioMed Ventures is a San Diego, California based venture capital firm. They are the investment arm of BioMed Realty. They are the investment arm of BioMed Realty. โฆSee details»
BioMedInvest III: Fund Performance - PitchBook
European Investment Fund: Fund of Funds: Current: 01-Feb-2018: Original: To view BioMedInvest IIIโs complete limited partners history, request access » BioMedInvest III โฆSee details»
BioMedPartners schliessen Wagniskapitalfonds - Basel Area โฆ
Mar 6, 2018 Das Basler Wagniskapitalunternehmen BioMedPartners hat den Fonds BioMedInvest III mit einem Kapital von 100 Millionen Franken geschlossen. Durch โฆSee details»
Shanghai Biomedical Industrial Equity Investment Fund
Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry. New. ... Shanghai Biomedical Industrial Equity Investment โฆSee details»
Biomedical Innovation II fund closure | Wellington UK Professional
BOSTON, 13 APRIL 2023 โ Wellington Management (โWellingtonโ or the โFirmโ), one of the worldโs largest independent investment management firms, today announced the close of โฆSee details»
Fluid Biomed Closes $27 Million USD Series A to Fund Expanded โฆ
Jan 7, 2025 Calgary-based medical device start-up Fluid Biomed has secured $27 million USD in Series A funding to fuel the development of its innovative stent for brain aneurysms. Fluid โฆSee details»
BioMedPartners closes new venture capital fund - BaseLaunch
Mar 6, 2018 The Basel-based company will invest 100 million Swiss francs in 12 to 15 biopharmaceutical, medical device and diagnostics companies. It will also take an active role โฆSee details»
Micron Biomedical - Funding, Financials, Valuation & Investors
Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market. New. ... How much funding has this organization raised over time? โฆSee details»
BioMedInvest I: Fund Performance - PitchBook
BioMedInvest I General Information Description. BioMedInvest I is a venture capital fund managed by BioMedPartners. The fund is located in Basel, Switzerland, and invested in โฆSee details»
Programme Invest In Biomed - Eurobiomed
The Invest In Biomed program is made for you! Le programme Invest In Biomed. 6 workshops collective or individual March to June 2025, led by experts in health and fundraising. Mars โฆSee details»
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services ...
6 days ago Humaneticsโ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out โฆSee details»
Patricia Industries' subsidiary Advanced Instruments to acquire and ...
4 days ago Following the closing of the transaction, Advanced Instruments and Nova Biomedical will merge, creating a global life science tools platform that will operate under the Nova โฆSee details»
Principles for the Future of Biomedical Research in the United โฆ
Feb 19, 2025 The US National Institutes of Health (NIH) is the largest public funder of biomedical and behavioral research in the world, investing most of its nearly $48 billion annual โฆSee details»
Programme Invest In Biomed - Eurobiomed
Le programme Invest In Biomed. 6 ateliers collectifs ou individuels de mars à juin 2025, animés par des experts en santé et levée de fonds. Mars 2025. Mars 2025. Revue flash de votre โฆSee details»
A Turn Around for Origin BioMed | Government of Nova Scotia โฆ
Dec 2, 2013 Origin BioMed's performance has increased customer demand for its product and now new marketing and distribution is needed in its larger markets. Nova Scotia Business Inc. โฆSee details»